HIV-Infection and Associated Dermatoses
The skin as the largest body organ is an important marker for an underlying HIV infection. There is a broad spectrum of skin symptoms and diseases that can be seen arising as a result of the underlying infection and progressing severity of the disease, enabling the dermatologist to make early diagnosis. Depending on the immune status of the patient, various cutaneous manifestations occur. While the majority of them improve as the immune status stabilizes, some may present a paradox by either worsening or clinically becoming more apparent. Drugs used to treat HIV, such as the highly active antiretroviral therapy (HAART), can themselves lead to significant side effects that manifest on the skin.
- 17.Guarneri C, Tchernev G, Bevelacqua V, et al. The unwelcome trio: HIV plus cutaneous and visceral leishmaniasis. Dermatol Ther. 2016;29(2):88–91. series: Int J STD AIDS 2016; 27: 1342–45.Google Scholar
- 26.Gromley RH, Kovarick CL. Human papillomavirus-related genital disease in the immunocompromised host. J Am Acad Dermatol. 2012;66:867–99.Google Scholar
- 27.Centers for Disease Control and Prevention, Workworski KA, Berman SM. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep. 2006;55:62–7.Google Scholar
- 32.WHO. Consolidated guidelines on: The Use of Antiretroviral Drugs for Treating and Preventing HIV Infection; recommendations for a public health approach, 2nd edition. 2016. ISBN:9789241549684.Google Scholar
- 35.Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010;3:CD008272.Google Scholar